Correction: Tislelizumab in Chinese patients with advanced solid tumors: an open-label, non-comparative, phase 1/2 study

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7371019/
https://www.ncbi.nlm.nih.gov/pubmed/32690666
http://dx.doi.org/10.1136/jitc-2019-000437corr1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7371019/
https://www.ncbi.nlm.nih.gov/pubmed/32690666
http://dx.doi.org/10.1136/jitc-2019-000437corr1

Ejemplares similares